Honglei Wang

Papers

Total Citations

H-Index

About

Honglei Wang is a pioneering figure in urologic oncology, with a focused expertise in robotic-assisted surgery for early-stage renal cancer. His most cited work, a 2025 prospective study, delivers a landmark comparison of three robotic systems—two Chinese platforms and the da Vinci Xi—in robot-assisted partial nephrectomy. By analyzing 170 patients, Wang demonstrated that the Chinese systems achieve comparable perioperative safety and efficacy to the global gold standard, a finding with profound implications for surgical accessibility and cost reduction. This contribution, already garnering 5 citations, underscores his role in advancing minimally invasive techniques and validating domestic surgical technology. Wang’s research directly addresses critical questions in oncologic surgery: how to maintain high-quality outcomes while expanding robotic options. His work not only informs clinical decision-making but also supports the broader adoption of robotic systems in resource-varied settings. For students and researchers, Wang exemplifies how rigorous comparative studies can drive innovation and equity in surgical care, making his profile essential for those exploring the future of robotic urology.